Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
clostridium infections
MeSH D003015 - clostridium infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016908:
Gram-positive bacterial infections
47 Companies
13 Drugs
$
Success rate
D003015:
Clostridium infections
41 Companies
10 Drugs
$
Success rate
D001906:
Botulism
9 Companies
3 Drugs
$
Success rate
D004761:
Pseudomembranous enterocolitis
88 Companies
13 Drugs
$
Success rate
D004767:
Enterotoxemia
0 Companies
0 Drugs
Success rate
D005738:
Gas gangrene
0 Companies
0 Drugs
Success rate
D013742:
Tetanus
91 Companies
10 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Merck Sharp & Dohme
Bezlotoxumab
Zinplava
2016-10-21
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
40
%
2/5
Phase 2
89
%
8/9
Phase 3
68
%
13/19
Approved:
9
Overall Success rate:
24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Ceftriaxone
,
Lidocaine
Sanofi
Sodium chloride
Merck Sharp & Dohme
Bezlotoxumab
,
Antithrombin iii
,
Sodium chloride
Pfizer
Tigecycline
,
Sodium chloride
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use